The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating PD-L1 (programmed death-ligand 1) and outcomes in a HER2-positive metastatic breast cancer cohort treated with first-line trastuzumab.
 
Ayesha Ali
No Relationships to Disclose
 
Laura Krecko
No Relationships to Disclose
 
Kim Leitzel
Research Funding - Novartis; Theranostics Health
 
Suhail M. Ali
No Relationships to Disclose
 
Joseph J. Drabick
Honoraria - Merck; Novartis
 
E Scott Halstead
No Relationships to Disclose
 
Vinod Nagabhairu
No Relationships to Disclose
 
Eric Marks
Honoraria - Brand Institute; Medscape; Sermo
 
Hyma Vani Polimera
No Relationships to Disclose
 
Angelique Ellerbee Richardson
No Relationships to Disclose
 
Robert Evans
Employment - R & D Systems Inc.
 
Howard Spiegel
Employment - ProteinSimple
 
Wolfgang Köstler
Stock and Other Ownership Interests - Express Scripts; GlaxoSmithKline K.K.
Consulting or Advisory Role - Bayer; MSD; Sanofi
 
Francisco J. Esteva
Consulting or Advisory Role - Celgene; Celltrion; Genentech/Roche; NanoString Technologies; Novartis; Spectrum Pharmaceuticals
Research Funding - Kadmon (Inst); Merrimack (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Myriad Genetics (royalties)
Travel, Accommodations, Expenses - Novartis
 
Allan Lipton
Research Funding - Novartis